Full Paper
(1.6m, 1.70 mL, 1.6 equiv) was added dropwise by means of a sy-
ringe. The solution turned brown and after 45 min at that tempera-
ture neat tributylborate (0.455 mL, 1.7 mmol, 1.5 equiv) was added.
The low-temperature bath was removed and the solution was al-
lowed to warm to RT over a period of 1 h or more. In the mean-
time, the solution turned red and then pale orange. Finally, the
content was transferred by means of a syringe to a second Schlenk
tube containing 4-bromothiazole (270 mg, 1.1 mmol, 1 equiv),
sodium carbonate (179 mg, 1.7 mmol, 1.5 equiv), and tetrakis(tri-
phenylphosphine) palladium(0) (39 mg, 3 mol%) dissolved in a de-
gassed 1:1 mixture of DME/water. The combined solution was
warmed at 65–758C until TLC showed reaction completion. The
crude mixture was allowed to cool to RT, diluted with water, and
extracted with ethyl acetate. The organic phase was combined,
dried over anhydrous magnesium sulfate, filtered, and the solvent
was removed. Purification by flash chromatography (silica, hexane/
CHCl3, 9/1, v/v) afforded 4 as a white powder (460 mg, 90%). M.p.
TLC monitoring showed completion it was partitioned between an
aqueous layer and ethyl acetate. The biphasic system was filtered
through a pad of Celite and the organic phase was separated,
dried over anhydrous magnesium sulfate, and filtered. After remov-
al of the solvents, the crude product was purified by flash chroma-
tography (silica, hexane/CHCl3) to afford 6 as a white solid
(270 mg, 85%). M.p. 57–608C; 1H NMR (300 MHz, CDCl3): d=1.92
(s, 3H), 3.77 (s, 3H), 7.14–7.42 (m, 8H), 7.53 (d, 1H, J=6 Hz), 7.56
(d, 1H, J=6 Hz), 7.85–7.93 ppm (m, 3H); 13C NMR (75 MHz, CDCl3):
d=12.3, 61.4, 109.8, 122.0, 122.2, 122.7, 123.9, 124.1, 124.7, 124.8,
126.3, 127.1, 128.8, 128.9, 129.7, 130.9, 131.7, 133.6, 135.5, 137.6,
~
139.2, 139.8, 146.0, 161.1, 163.9 ppm; IR: n=3058, 2835, 1597,
1575, 1542, 1512, 1493, 1460, 1449, 1423, 1312, 1266, 1155, 1139,
1017, 756, 726 cmꢀ1; HRMS (EI): m/z calcd for C27H19NOS3 [M+]:
469.0629; found: 469.0619.
Synthesis of 7
1
145–1488C; H NMR (300 MHz, CDCl3): d=3.87 (s, 3H), 6.80 (s, 1H),
7.14–7.44 (m, 9H), 7.76–7.98 ppm (m, 4H); 13C NMR (75 MHz,
CDCl3): d=61.7, 109.2, 114.6, 122.0, 122.2, 122.3, 123.2, 123.3,
124.2, 124.3, 124.8, 125.0, 126.6, 128.9, 130.1, 131.3, 133.2, 136.6,
A Schlenk tube was charged with benzothiophene (791 mg,
6 mmol, 3 equiv), D (500 mg, 2 mmol, 1 equiv), PivOH (60 mg,
30 mol%), P(tBu)2MeHBF4 (49 mg, 10 mol%), anhydrous cesium car-
bonate (1.28 g, 4 mmol, 2 equiv), and palladium(II) acetate (22 mg,
5 mol%) under a stream of nitrogen. Dry mesitylene was added by
means of a syringe (3 mL) and the suspension was evacuated/back-
filled with nitrogen several times. The mixture was heated at
1408C (at high temperature the reactants solubilize and the reac-
tion starts). The mixture was allowed to cool to RT and after TLC
monitoring showed completion it was partitioned between an
aqueous layer and ethyl acetate. The biphasic system was filtered
through a pad of Celite and the organic phase was separated,
dried over anhydrous magnesium sulfate, and filtered. After remov-
al of solvent, the crude product was purified by column chroma-
tography (silica, hexane/CHCl3, 1:4, v/v) to afford 7 as a white solid
(550 mg, 91%). M.p. 95–978C; 1H NMR (300 MHz, CDCl3): d=2.70
(s, 3H), 7.31–7.58 (m, 5H), 7.77 (s, 1H), 7.79–7.97 ppm (m, 4H);
13C NMR (75 MHz, CDCl3): d=13.0, 121.4, 122.1, 123.6, 124.3, 126.3,
128.8, 129.0, 129.9, 133.3, 138.6, 139.7, 140.3, 145.8, 163.6 ppm; IR:
~
137.5, 138.9, 140.7, 149.5, 161.6, 166.6 ppm; IR: n=3133, 3057,
3010, 1598, 1573, 1551, 1532, 1502, 1486, 1464, 1447, 1434, 1420,
1357, 1316, 1282, 1262, 1233, 1183, 1155, 1016, 1002, 763, 743,
724 cmꢀ1; HRMS (EI): m/z calcd for C26H18NOS3 [M+H]+: 456.0551;
found: 456.0552.
Synthesis of 5
A Schlenk tube was charged with 2a (250 mg, 0.9 mmol, 1 equiv),
D
(227 mg, 0.9 mmol, 1 equiv), PivOH (27 mg, 30 mol%),
P(tBu)2MeHBF4 (22 mg, 10 mol%), anhydrous cesium carbonate
(582 mg, 1.8 mmol, 2 equiv), and palladium(II) acetate (10 mg,
5 mol%) under a stream of nitrogen. Dry mesitylene was added by
means of a syringe (3 mL) and the suspension was evacuated/back-
filled with nitrogen several times. The mixture was heated at
1408C (at high temperature the reactants solubilize and the reac-
tion starts). The mixture was allowed to cool to RT and after TLC
monitoring showed completion it was partitioned between an
aqueous layer and ethyl acetate. The biphasic system was filtered
through a pad of Celite and the organic phase was separated,
dried over anhydrous magnesium sulfate, and filtered. After remov-
al of the solvent, the crude product was purified by flash chroma-
tography (silica, hexane/CHCl3) to afford 5 as a white solid
~
n=3048, 3018, 2852, 1493, 1455, 1440, 1311, 1244, 1197, 1152,
1125, 1067, 1015, 976, 826, 762, 744, 725 cmꢀ1; HRMS (EI): m/z
calcd for C18H13NS2 [M+]: 307.0489; found: 307.0497.
Synthesis of 8
A brown-glass, round-bottomed flask was charged with 5 (400 mg,
1.3 mmol, 1 equiv) and THF (13 mL). NBS (255 mg, 1.4 mmol,
1.1 equiv) was added in one portion at 08C and the mixture was al-
lowed to slowly warm to RT overnight. Water was added and the
suspension was extracted with ethyl acetate. The organic phase
was washed with an approximately 1m aqueous solution of NaOH,
then with water, dried over anhydrous magnesium sulfate, and fi-
nally filtered. The solvent was removed and the crude product was
used without further purification (500 mg, 99%). M.p. 88–908C;
1H NMR (300 MHz, CDCl3): d=2.51 (s, 3H), 7.38–7.46 (m, 5H), 7.79–
7.95 (m, 4H); 13C NMR (75 MHz, CDCl3): d=13.2, 108.4, 122.2, 123.6,
125.1, 125.7, 126.3, 128.8, 129.9, 132.4, 133.3, 133.6, 138.1, 138.6,
1
(250 mg, 62%). M.p. 145–1488C; H NMR (300 MHz, CDCl3): d=1.82
(s, 3H), 2.22 (s, 3H), 7.18–7.43 (m, 11H), 7.77–7.96 ppm (m, 4H);
13C NMR (75 MHz, CDCl3): d=12.3, 14.9, 121.9, 122.2, 123.0, 123.7,
123.9, 124.1, 124.2, 124.8, 126.3, 127.3, 128.7, 128.8, 129.7, 131.9,
133.5, 136.0, 138.2, 138.8, 139.5, 139.7, 139.8, 145.6, 164.1 ppm; IR:
~
n=3054, 2946, 1948, 1512, 1496, 1453, 1430, 1308, 1289, 1263,
1250, 1171, 1155, 1142, 1021, 971, 759, 740, 726 cmꢀ1; HRMS (EI):
m/z calcd for C26H19NS3 [M+]: 453.0680; found: 453.0681.
Synthesis of 6
~
A Schlenk tube was charged with 2b (200 mg, 0.7 mmol, 1 equiv),
144.1, 164.7 ppm; IR: n=3058, 2920, 2847, 1505, 1489, 1488, 1460,
D
(172 mg, 0.7 mmol, 1 equiv), PivOH (21 mg, 30 mol%),
1437, 1306, 1277, 1250, 1162, 1070, 1017, 968, 814, 749, 719 ppm;
HRMS (EI): m/z calcd for C18H1NBrS2 [M+]: 384.9595; found
384.9606.
P(tBu)2MeHBF4 (17 mg, 10 mol%), anhydrous cesium carbonate
(441 mg, 14 mmol, 2 equiv), and palladium(II) acetate (8 mg,
5 mol%) under a stream of nitrogen. Dry mesitylene was added by
means of a syringe (2.3 mL) and the suspension was evacuated/
backfilled with nitrogen several times. The mixture was heated at
1408C (at high temperature the reactants solubilize and the reac-
tion starts). The mixture was allowed to cool down RT and after
Synthesis of 9
A Schlenk tube equipped with a magnetic stirring bar and capped
with a rubber septum was charged with 6 (361 mg, 0.9 mmol,
&
&
Chem. Eur. J. 2015, 21, 1 – 13
10
ꢀ 2015 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ÝÝ These are not the final page numbers!